Effect of Patisiran on Polyneuropathy and Cardiomyopathy in Patients with hATTR Amyloidosis with V122I/T60A Variants: A Phase 4 Observational Study (S14.005)

Raymond L Comenzo,Joel Fernandez,Kelley Capocelli,Yessar Hussain,Elena Yureneva,Urvi Desai,Ronald Zolty,Saurabh Malhotra,Francy Shu,Lin-Na Chou

doi:10.1212/wnl.0000000000202917

Effect of Patisiran on Polyneuropathy and Cardiomyopathy in Patients with hATTR Amyloidosis with V122I/T60A Variants: A Phase 4 Observational Study (S14.005)

Raymond L Comenzo, Joel Fernandez + Show 8 more

https://doi.org/10.1212/wnl.0000000000202917

Copy DOI

Export

Save

Cite

Journal: Neurology

Publication Date: Apr 25, 2023

Affiliation: Tufts Medical Center, Alnylam Pharmaceuticals (United States), Carolinas Healthcare System, University of Nebraska Medical Center, Cook County Health and Hospitals System, UCLA Medical Center

#Polyneuropathy Disability Score #hATTR Amyloidosis #Scientific Advisory #Received Research Support #Composite Autonomic Symptom Score-31 #Scientific Data #Kansas City Cardiomyopathy Questionnaire #Severity Of Cardiac Dysfunction #Norfolk QOL-DN #Polyneuropathy Disability

Abstract
Full-Text
Similar Papers

Abstract

Listen

Effect of Patisiran on Polyneuropathy and Cardiomyopathy in Patients with hATTR Amyloidosis with V122I/T60A Variants: A Phase 4 Observational Study (S14.005)

Full Text

Published Version

Check institute access

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Neurology

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.

R Discovery Prime

Effect of Patisiran on Polyneuropathy and Cardiomyopathy in Patients with hATTR Amyloidosis with V122I/T60A Variants: A Phase 4 Observational Study (S14.005)